Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0500
+0.0050 (11.11%)
Aug 12, 2025, 3:02 PM EDT
Bally's Revenue
In the fiscal year ending August 31, 2024, Lobe Sciences had annual revenue of 136.21K CAD, down -83.80%.
Revenue
136.21K
Revenue Growth
-83.80%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 136.21K | -704.33K | -83.80% |
| Aug 31, 2023 | 840.53K | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | - | - | - |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.57B |
| Curaleaf Holdings | 1.75B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| WELL Health Technologies | 990.34M |
| Cronos Group | 177.69M |
| Extendicare | 1.51B |